Mesenchymal Stem Cell Derived A-1 Exosomes for Traumatic Brain Injury
间充质干细胞衍生的 A-1 外泌体治疗创伤性脑损伤
基本信息
- 批准号:10411928
- 负责人:
- 金额:$ 56.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-06-15 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdverse effectsAlzheimer&aposs DiseaseAnimal ModelAnti-Inflammatory AgentsBehaviorBehavioralBiological AssayBrainCaringCell TherapyCellsChronicChronic DiseaseChronic PhaseClinicalCognitiveDiseaseDisease modelDistressDoseDrug KineticsHealthcare SystemsInflammationInflammatory ResponseInjuryIntranasal AdministrationIntravenousLearningLipidsLocationMeasuresMedicalMemoryMesenchymalMesenchymal Stem CellsMetabolicMolecularMoodsMusNatural ImmunityParkinsonian DisordersPatientsPatternPharmaceutical PreparationsPhaseProblem behaviorPropertyProteomicsProtocols documentationPublicationsRNAReactionReagentReportingRouteSafetyShort-Term MemorySiteSocietiesStandardizationStressStromal CellsSwimmingSyndromeTBI treatmentTestingTherapeutic IndexTraumatic Brain InjuryTravelVesicleacquired immunityadult stem cellbasebehavior testbehavioral impairmentcytokinedepressive symptomseffective therapyexosomefeedingimprovedmouse modelneuroinflammationnovelnovel therapeuticsobject recognitionpreventstemwater maze
项目摘要
Project Summary/Abstract
“Mesenchymal Stem Cell Derived A1-Exosomes for Traumatic Brain Injury”
This proposal will develop a novel therapy for severe traumatic brain injury (TBI), a
condition that has devastating effects on the victims and creates a large burden over
$55 billion per year on the US healthcare system. One of the distressing features of TBI
is that after the acute phase, the patients gradually develop behavioral deficits. As a
result, the disease is now considered as a chronic syndrome that involves a viscous
cycle in which the initial inflammatory response is excessive so that it causes
considerable injury to the brain and thereby triggers another round of lasting
inflammation. Numerous anti-inflammatory agents have been tested for treating TBI, but
none have yet been accepted as part of standard medical care. This proposal is based
on earlier publications that demonstrated administration of mesenchymal stem/stromal
cells produced beneficial effects in animal models of TBI (by MSCs), primarily through
reducing inflammation, and the more recent observation by us and another lab that the
beneficial effects of MSCs can be reproduced with small vesicles (exosomes) produced
by MSCs. The proposed studies will establish the efficacy, safety, and mode of action of
A1-exosomes in a mouse model of TBI. A1-exosomes are prepared from MSCs with a
scalable protocol, which can be used as “off-the-shelf” reagents. We will compare the
administration of A1-exosomes either intravenously or intranasally since we have
recently found that intranasal administration of A1-exosomes dramatically reduces
induced-neuroinflammation. If successful, the proposal will provide the basis for a novel
clinical therapy for TBI and perhaps other diseases involving neuroinflammation such as
Parkinsonism and Alzheimer’s disease.
项目总结/文摘
项目成果
期刊论文数量(37)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Melatonin improves brain function in a model of chronic Gulf War Illness with modulation of oxidative stress, NLRP3 inflammasomes, and BDNF-ERK-CREB pathway in the hippocampus.
- DOI:10.1016/j.redox.2021.101973
- 发表时间:2021-07
- 期刊:
- 影响因子:11.4
- 作者:Madhu LN;Kodali M;Attaluri S;Shuai B;Melissari L;Rao X;Shetty AK
- 通讯作者:Shetty AK
Proficiency of Extracellular Vesicles From hiPSC-Derived Neural Stem Cells in Modulating Proinflammatory Human Microglia: Role of Pentraxin-3 and miRNA-21-5p.
- DOI:10.3389/fnmol.2022.845542
- 发表时间:2022
- 期刊:
- 影响因子:4.8
- 作者:Upadhya R;Madhu LN;Rao S;Shetty AK
- 通讯作者:Shetty AK
SARS-CoV-2 and Hypertension: Evidence Supporting Invasion into the Brain Via Baroreflex Circuitry and the Role of Imbalanced Renin-Angiotensin-Aldosterone-System.
- DOI:10.1177/26331055231151926
- 发表时间:2023
- 期刊:
- 影响因子:3.6
- 作者:Oliveira, Kellysson Bruno;de Melo, Igor Santana;da Silva, Bianca Rodrigues Melo;Oliveira, Keylla Lavinia da Silva;Sabino-Silva, Robinson;Anhezini, Lucas;Katayama, Pedro Lourenco;Santos, Victor Rodrigues;Shetty, Ashok K.;de Castro, Olagide Wagner
- 通讯作者:de Castro, Olagide Wagner
Promise of irisin to attenuate cognitive dysfunction in aging and Alzheimer's disease.
- DOI:10.1016/j.arr.2022.101637
- 发表时间:2022-06
- 期刊:
- 影响因子:13.1
- 作者:
- 通讯作者:
Patient-derived iPSC modeling of rare neurodevelopmental disorders: Molecular pathophysiology and prospective therapies.
- DOI:10.1016/j.neubiorev.2020.12.025
- 发表时间:2021-03
- 期刊:
- 影响因子:8.2
- 作者:Sabitha KR;Shetty AK;Upadhya D
- 通讯作者:Upadhya D
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ASHOK K SHETTY其他文献
ASHOK K SHETTY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ASHOK K SHETTY', 18)}}的其他基金
Neural Stem Cell-derived EVs for Improving Aged Brain Function
神经干细胞衍生的 EV 可改善老年脑功能
- 批准号:
10356721 - 财政年份:2022
- 资助金额:
$ 56.29万 - 项目类别:
Intranasal Treatment of Stem Cell-derived Extracellular Vesicles for Alzheimer's Disease
干细胞来源的细胞外囊泡鼻内治疗阿尔茨海默病
- 批准号:
10455945 - 财政年份:2022
- 资助金额:
$ 56.29万 - 项目类别:
Neural Stem Cell-derived EVs for Improving Aged Brain Function
神经干细胞衍生的 EV 可改善老年脑功能
- 批准号:
10670802 - 财政年份:2022
- 资助金额:
$ 56.29万 - 项目类别:
Mesenchymal Stem Cell Derived A-1 Exosomes for Traumatic Brain Injury
间充质干细胞衍生的 A-1 外泌体治疗创伤性脑损伤
- 批准号:
10186835 - 财政年份:2018
- 资助金额:
$ 56.29万 - 项目类别:
Combined NSC Grafting and Neurogenic Drug Therapy for Temporal Lobe Epilepsy
NSC 移植和神经源性药物联合治疗颞叶癫痫
- 批准号:
8967096 - 财政年份:2015
- 资助金额:
$ 56.29万 - 项目类别:
Combined NSC Grafting and Neurogenic Drug Therapy for Temporal Lobe Epilepsy
NSC 移植和神经源性药物联合治疗颞叶癫痫
- 批准号:
8732496 - 财政年份:2015
- 资助金额:
$ 56.29万 - 项目类别:
Memory and Mood Enhancing Therapies for Gulf War Illness
海湾战争疾病的记忆和情绪增强疗法
- 批准号:
8698618 - 财政年份:2011
- 资助金额:
$ 56.29万 - 项目类别:
Memory and Mood Enhancing Therapies for Gulf War Illness
海湾战争疾病的记忆和情绪增强疗法
- 批准号:
8402516 - 财政年份:2011
- 资助金额:
$ 56.29万 - 项目类别:
Memory and Mood Enhancing Therapies for Gulf War Illness
海湾战争疾病的记忆和情绪增强疗法
- 批准号:
8774531 - 财政年份:2011
- 资助金额:
$ 56.29万 - 项目类别:
Memory and Mood Enhancing Therapies for Gulf War Illness
海湾战争疾病的记忆和情绪增强疗法
- 批准号:
7997341 - 财政年份:2011
- 资助金额:
$ 56.29万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 56.29万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 56.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 56.29万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 56.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 56.29万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 56.29万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 56.29万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 56.29万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 56.29万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 56.29万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




